Trump signed an order instituting the levy on Thursday.

Within the sector, Sun Pharmaceutical Industries has emerged as the most exposed name, given its relatively higher dependence ...

President Trump has slapped 100% tariffs on some pharmaceutical products, ramping up his effort to boost U.S. drug ...

Jefferies’ report narrows the tariff conversation to a stock-specific level rather than a sector-wide concern. Sun Pharma ...

Parliamentary Panel asks DoP to address issues in RPTUAS for fund utilisation: Gireesh Babu, New Delhi Monday, April 6, 2026, 08:00 Hrs [IST] Taking note that no actual expenditur ...

Eli Lilly has won FDA approval for its oral obesity drug Foundayo™ (orforglipron), but the stock bounce was short lived as investors pondered how much in sales it will generate this year as a price ...

For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.

Indian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical ...

Trump’s new 100% tariffs on branded drugs and key pharma ingredients target Europe and Japan while largely sparing India’s ...

At first glance, the 100% tariff rate seems significant, but experts noted it would only apply to a small fraction of drugs used in the U.S. and is more likely to spur pricing and reshoring deals.

Whether the deal reaches its full value hinges on US regulatory milestones for Centessa’s lead candidate, cleminorexton.

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF)shares rose as much as 10% in Tuesday morning trading after the AIM-listed ...